• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-γ和白细胞介素-1对人脐静脉内皮细胞中补体因子H和C3产生的差异调节

Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1.

作者信息

Brooimans R A, van der Ark A A, Buurman W A, van Es L A, Daha M R

机构信息

Department of Nephrology, University Hospital, Leiden, The Netherlands.

出版信息

J Immunol. 1990 May 15;144(10):3835-40.

PMID:2139673
Abstract

Human umbilical vein endothelial cells (HUVEC) synthesize and secrete C component factors H and C3. Addition of T cell growth factor to HUVEC enhanced factor H production, and caused a profound increase in C3 production. In the present study, investigations were initiated to characterize the effects of purified rIL-1 and rIFN-gamma on the production of factor H and C3 at the protein and mRNA level. IFN-gamma enhanced factor H production in a dose-dependent fashion and a two-fold increase was observed with an optimal dose of 200 U/ml, whereas IFN-gamma had no effect on C3 production. IL-1 inhibited factor H secretion, but the production of C3 was increased 10-fold at an optimal dose of 500 pg/ml of IL-1. Kinetic experiments demonstrated that addition of IL-1 to HUVEC resulted in an induction of C3 production after more than 24 h, whereas IFN-gamma already had a significant effect on factor H production after 8 h of culture. IL-1 in combination with IFN-gamma had a synergistic effect on C3 production. The effects of IL-1 and IFN-gamma on factor H and C3 production by HUVEC could be blocked by using neutralizing amounts of antibodies specific for these cytokines. Northern blot analysis showed that factor H mRNA expression was enhanced in IFN-gamma-treated HUVEC and C3 mRNA was induced in IL-1-treated HUVEC, indicating that the observed increase of factor H and C3 probably is controlled by enhancement of transcription or stability of the transcript.

摘要

人脐静脉内皮细胞(HUVEC)合成并分泌补体成分因子H和C3。向HUVEC中添加T细胞生长因子可增强因子H的产生,并导致C3产生显著增加。在本研究中,开始进行调查以在蛋白质和mRNA水平上表征纯化的重组白细胞介素-1(rIL-1)和重组干扰素-γ(rIFN-γ)对因子H和C3产生的影响。干扰素-γ以剂量依赖性方式增强因子H的产生,在最佳剂量200 U/ml时观察到增加了两倍,而干扰素-γ对C3产生没有影响。白细胞介素-1抑制因子H的分泌,但在最佳剂量500 pg/ml的白细胞介素-1时C3的产生增加了10倍。动力学实验表明,向HUVEC中添加白细胞介素-1在超过24小时后导致C3产生的诱导,而干扰素-γ在培养8小时后已经对因子H的产生有显著影响。白细胞介素-1与干扰素-γ联合对C3产生有协同作用。使用针对这些细胞因子的中和量抗体可阻断白细胞介素-1和干扰素-γ对HUVEC产生因子H和C3的影响。Northern印迹分析表明,在干扰素-γ处理的HUVEC中因子H mRNA表达增强,在白细胞介素-1处理的HUVEC中C3 mRNA被诱导,表明观察到的因子H和C3的增加可能是由转录增强或转录本稳定性控制的。

相似文献

1
Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1.干扰素-γ和白细胞介素-1对人脐静脉内皮细胞中补体因子H和C3产生的差异调节
J Immunol. 1990 May 15;144(10):3835-40.
2
Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma.人脐静脉内皮细胞补体因子H的生物合成。受T细胞生长因子和γ干扰素调节。
J Immunol. 1989 Mar 15;142(6):2024-30.
3
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma.白细胞介素-1和γ干扰素对人肾小球系膜细胞C3及补体因子H合成的调节作用
Clin Exp Immunol. 1994 Jan;95(1):173-80. doi: 10.1111/j.1365-2249.1994.tb06033.x.
4
Effect of interferon-gamma on complement gene expression in different cell types.干扰素-γ对不同细胞类型中补体基因表达的影响。
Biochem J. 1992 Jan 15;281 ( Pt 2)(Pt 2):437-42. doi: 10.1042/bj2810437.
5
Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture.干扰素γ可诱导培养的人内皮细胞合成补体替代途径蛋白。
J Exp Med. 1988 Nov 1;168(5):1917-22. doi: 10.1084/jem.168.5.1917.
6
In vitro biosynthesis of complement factor I by human endothelial cells.人内皮细胞对补体因子I的体外生物合成
Eur J Immunol. 1992 Jan;22(1):213-7. doi: 10.1002/eji.1830220131.
7
TNF-alpha stimulates the biosynthesis of complement C3 and factor B by human umbilical cord vein endothelial cells.肿瘤坏死因子-α刺激人脐静脉内皮细胞合成补体C3和B因子。
Cancer Lett. 1997 Jun 3;116(1):21-6. doi: 10.1016/s0304-3835(97)04737-x.
8
IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.白细胞介素-1与肿瘤坏死因子。人成纤维细胞中补体替代途径及干扰素-β2/白细胞介素-6基因表达刺激方面的异同
J Immunol. 1989 Jun 1;142(11):3862-7.
9
Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a.白细胞介素-1α和糖皮质激素激活内皮细胞会导致补体C3和B因子生成大幅增加以及C3a的产生。
Clin Exp Immunol. 1995 Jul;101(1):142-9. doi: 10.1111/j.1365-2249.1995.tb02290.x.
10
Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids.内皮细胞中补体替代途径蛋白的表达。白细胞介素1和糖皮质激素的差异调节。
Eur J Immunol. 1990 Aug;20(8):1669-75. doi: 10.1002/eji.1830200808.

引用本文的文献

1
Chronic kidney disease enhances alternative pathway activity: a new paradigm.慢性肾脏病增强替代途径活性:一种新范式。
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188353.
2
Production, purification, and quality assessment of borrelial proteins CspZ from Borrelia burgdorferi and FhbA from Borrelia hermsii.从伯氏疏螺旋体和赫姆斯疏螺旋体中生产、纯化和质量评估 CspZ 蛋白和 FhbA 蛋白。
Appl Microbiol Biotechnol. 2024 Jul 23;108(1):425. doi: 10.1007/s00253-024-13195-2.
3
Protective role of complement factor H against the development of preeclampsia.
补体因子H对先兆子痫发展的保护作用。
Front Immunol. 2024 Feb 23;15:1351898. doi: 10.3389/fimmu.2024.1351898. eCollection 2024.
4
The human factor H protein family - an update.人因子 H 蛋白家族——更新。
Front Immunol. 2024 Feb 12;15:1135490. doi: 10.3389/fimmu.2024.1135490. eCollection 2024.
5
Complement factor H: a novel innate immune checkpoint in cancer immunotherapy.补体因子H:癌症免疫治疗中一种新型的固有免疫检查点。
Front Cell Dev Biol. 2024 Feb 8;12:1302490. doi: 10.3389/fcell.2024.1302490. eCollection 2024.
6
Upregulation of complement proteins in lung cancer cells mediates tumor progression.肺癌细胞中补体蛋白的上调介导肿瘤进展。
Front Oncol. 2023 Jan 5;12:1045690. doi: 10.3389/fonc.2022.1045690. eCollection 2022.
7
Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside.检测补体攻击血管内皮细胞的方法:从研究到临床。
Front Immunol. 2022 Apr 12;13:860689. doi: 10.3389/fimmu.2022.860689. eCollection 2022.
8
Targeting vascular inflammation through emerging methods and drug carriers.通过新兴方法和药物载体靶向血管炎症。
Adv Drug Deliv Rev. 2022 May;184:114180. doi: 10.1016/j.addr.2022.114180. Epub 2022 Mar 7.
9
The role of complement factor H in gestational diabetes mellitus and pregnancy.补体因子 H 在妊娠糖尿病和妊娠中的作用。
BMC Pregnancy Childbirth. 2021 Aug 17;21(1):562. doi: 10.1186/s12884-021-04031-w.
10
Aberrant activation of the complement system in renal grafts is mediated by cold storage.在肾脏移植物中,补体系统的异常激活是由冷储存介导的。
Am J Physiol Renal Physiol. 2021 Jun 1;320(6):F1174-F1190. doi: 10.1152/ajprenal.00670.2020. Epub 2021 May 17.